Bangladesh vs Europe (WHO region): Previously treated cases tested for RR-/MDR-TB
Bangladesh
100.0%
in 2024
Europe (WHO region)
90.0%
in 2024
Bangladesh rank
1st
Europe (WHO region) rank
2nd
Previously treated cases tested for RR-/MDR-TB over time
- Bangladesh
- Europe (WHO region)
How they compare
Bangladesh currently reports 100.0% against 90.0% in Europe (WHO region), a difference of 10.0%.
That makes Bangladesh's figure about 1.1 times Europe (WHO region)'s.
The two have swapped places 7 times across 15 shared years of data; in 2010 it was Europe (WHO region) ahead.
Bangladesh ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
Across the 2 decades both report, Bangladesh averaged higher in 1 and Europe (WHO region) in 1.
Head to head by decade
| Decade | Bangladesh | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 51.4% | 57.7% | 6.3% | Europe (WHO region) |
| 2020s | 96.0% | 93.8% | 2.2% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Bangladesh or Europe (WHO region)?
- Bangladesh, at 100.0% against 90.0% in Europe (WHO region) as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Bangladesh and Europe (WHO region)?
- 10.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Europe (WHO region)?
- 15 years are reported by both, from 2010 to 2024.
- How do Bangladesh and Europe (WHO region) rank globally for previously treated cases tested for rr-/mdr-tb?
- Bangladesh ranks 1st and Europe (WHO region) ranks 2nd of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.